ABBIOTEC
位于生技圣地--美國圣地亞哥的Abbiotec，是2007年新成立的一間生物技術(shù)公司，其產(chǎn)品在生命科學(xué)實(shí)驗(yàn)有著廣泛的應(yīng)用；Abbiotec公司專注于開發(fā)抗體，多肽，蛋白等試劑和使其不斷市場(chǎng)化；Abbiotec的專有技術(shù)使其能夠高效的挑選，設(shè)計(jì)和生產(chǎn)抗體，裂解物，以及各種試劑，讓研究人員能夠更專注于他們的研究。高質(zhì)量、創(chuàng)新與完整的產(chǎn)品、合理的價(jià)格為Abbiotec不變的堅(jiān)持與承諾；Abbiotec將不斷為滿足客戶的需要和讓他們獲得更好的成果而努力。產(chǎn)品系列主要包括：Antibodies、Peptides、Proteins、Lysates、Kits and Reagents
Abbiotec is a company focused on developing and commercializing next generation antibodies and reagents for the life science research community. Our proprietary technologies allow us to select, design, and produce antibodies, lysates, and various reagents with a high degree of skill and efficiency so researchers can better focus their energies on their experimental designs and ideas.
Abbiotec is a different type of reagent company for a new century of demanding and exciting research projects and ideas. Our tools enable the study of human biology and disease at the cellular and molecular levels, with cross applications in diagnostic assays that we hope may eventually lead to promising therapeutics.
Abbiotec will also offer various complementary kits and solutions in the areas of genomics, proteomics, cell and tissue culture, and areas important for studies in functional genomics, signaling pathways, immunology, cancer, and brain disorders.
At Abbiotec, we believe that a strong relationship with our research community is the surest way to show our dedication and pride in our work and to allow for the maximum of success and satisfaction to our customers.
深圳市豪地華拓生物科技有限公司為Abbiotec中國大陸唯一授權(quán)代理
Otwo Biotech (shenzhen) Inc.
ABBIOTEC官網(wǎng)授權(quán)信息：
http://www.abbiotec.com/distributors/asia-&-pacific-rim
丁香通-品牌專區(qū)認(rèn)證授權(quán)代理信息：
https://www.biomart.cn/brand/4028e4e633f365960133f75ee35b3da6/brand.htm
PL Laboratories Inc. 簡(jiǎn)稱PLLABS，2005年成立于加拿大溫哥華，PLLABS專注于生命科學(xué)和 醫(yī)藥技術(shù)開發(fā)領(lǐng)域，擁有專業(yè)且一流的技術(shù)團(tuán)隊(duì)，為全球科研用戶和生物醫(yī)藥企業(yè)提供高質(zhì)量的產(chǎn)品和可 靠的技術(shù)服務(wù)來滿足客戶和合作伙伴全方位和長遠(yuǎn)發(fā)展的需要；PLLABS技術(shù)團(tuán)隊(duì)豐富的研發(fā)經(jīng)驗(yàn)和勇于開 拓創(chuàng)新使得PLLABS能在生物技術(shù)不斷發(fā)展的今天依然能保持優(yōu)勢(shì)?，F(xiàn)有常規(guī)產(chǎn)品兩萬余種：包括單克隆和 多克隆抗體，多肽，化合物，藥物中間體，藥物肽，化妝品肽等，并能供應(yīng)診斷試劑所需的抗體和相關(guān)產(chǎn) 品，同時(shí)也提供抗體制備、多肽合成和醫(yī)藥相關(guān)技術(shù)開發(fā)服務(wù)。
PL Laboratories was established to facilitate current scientific research and drug discovery. Our aim is to provide quality products and reliable scientific services to meet the full needs or beyond the expectation of our customers and collaborators. PL Laboratories specialize in antibody production, peptide synthesis and related products and services, including amino acids, Fmoc amino acids and Boc amino acids for peptide synthesis, and recombinant proteins. PL Laboratories always strives to expand and optimize our products and services on an on-going basis.
Our products include:
· Polyclonal and monoclonal antibodies
· Peptides and proteins
· Elisa and other test kits
· Chemicals including Fmoc amino acids, Boc amino acids and coupling agents
In addition to our research-related specialty chemicals and biological reagents, we also offer bulk products and OEM services for the production of pharmaceutical intermediates, pharmaceutical peptides, cosmetic peptides, diagnostic antibodies and healthcare antibodies.
Our philosophy is to offer you the highest quality products and services, no matter you are a novice or an expert in the scientific field. We are here to work together with you in moving toward your research goals or commercial targets. With PL Laboratories, you have our full commitment to support your efforts in every possible way.
深圳市豪地華拓生物科技有限公司為PLLABS中國大陸唯一授權(quán)代理
PLLABS官網(wǎng)授權(quán)代理信息：
http://www.pllabs.com/about-us/
丁香通-品牌專區(qū)認(rèn)證授權(quán)代理信息：
https://www.biomart.cn/brand/ff8080814cf9f010014cfe231e317df4/brand.htm
Genemed Synthesis Inc (GSI) 1994年創(chuàng)立于美國舊金山，主要提供多肽合成，抗體制備和引物合成服務(wù)。GSI公司也生產(chǎn)和提供上千種的單克隆和多克隆抗體，各種動(dòng)物的二抗和標(biāo)記二抗，幾百種人和動(dòng)物的ELISA試劑盒等產(chǎn)品。十余年的研發(fā)和服務(wù)經(jīng)驗(yàn)使得GSI贏得了成千上萬研究人員的信任與支持，其產(chǎn)品也被更多的應(yīng)用并發(fā)表在各種刊物上。2007年GSI公司從舊金山搬遷至德克薩斯州的圣安東尼奧，GSI將為全世界的科研人員提供更多更優(yōu)質(zhì)的產(chǎn)品服務(wù)。
Genemed Synthesis Inc (GSI) was established in 1994 in San Francisco to offer quality services in the area of custom peptides, custom antibodies, and custom Oligo (DNA) synthesis. In the early 1990s, there were not too many commercial companies offering such services. Synthesis of peptides and antibodies, cloning and expression of genes was worth researcher’s own time and often resulted into high quality publications. Most universities and institutions operated their own in-house ‘core facilities’ to meet the demands of their scientists. Therefore, in the early phases of sub-contracting of scientific experiments and research projects, it was more about earning the trust of scientific community than the actual sub-contracting expenses.
Genemed Synthesis Inc (GSI) was not only one of the selected few companies who ventured early into the commercialization of custom peptide, antibodies, and oligo (DNA) synthesis but it continued to offer better product and services through innovations and the use of latest instruments. As a result, GSI has been able to offer better quality at reduced prices and quicker turn around time. GSI can now make peptides up to ~100 amino acids perform many complex peptide modifications. Oligo (20-50 bases) can be made, quality tested and shipped within 24-hrs. Using more sophisticated DNA synthesizers and sequencers, GSI can synthesize genes up to 1-2 kb and verify by DNA sequencing. It is often quicker and less expansive to synthesize short genes than to clone them. Synthetic genes can also be cloned, expressed, and recombinant proteins purified for a variety of uses including antibody production.
More than a decade of dedicated services, Genemed Synthesis Inc (GSI) is really honored to earn the trust of 1000s of scientists all over the world. We take pride in 1000s of top-quality publications from the use of our products and services. When asked about GSI’s expertise references, we simply refer to the growing list of publications instead of relying upon so called ‘testimonials’ or ‘statements’ from unknown users.
With the completion of ‘Human Genome Project’ in 2003, we have witnessed the most amazing and monumental scientific achievement in the history of mankind. It will not be too long when fruits of this labor are realized in the form of new drugs, diagnosis and treatments of many diseases and new gene therapies. With the availability of human and other species genomes, there is an ever increasing demand for Genemed Synthesis Inc (GSI) product and services. In May 2007, Genemed Synthesis Inc (GSI) has moved from San Francisco, CA to San Antonio, TX to expand its operations and offer better services.
Genemed Synthesis Inc (GSI) remains obliged and thankful to all scientists who continued to support GSI.
深圳市豪地華拓生物科技有限公司為Genemed Synthesis Inc (GSI)中國大陸唯一授權(quán)代理
Genemed Synthesis Inc (GSI)官網(wǎng)授權(quán)代理信息：
丁香通-品牌專區(qū)認(rèn)證授權(quán)代理信息：
https://www.biomart.cn/brand/ff80808149a7c69e0149ac2be59a2c02/brand.htm
美國 Fluorochorome 公司于1985 年成立于美國科羅拉多州丹佛市，F(xiàn)luorochorome 一直 致力于熒光染料的研究與開發(fā)，其專利產(chǎn)品Fluoro Gold（熒光金）自 1985 年來在全球范圍 內(nèi)被廣泛應(yīng)用，并有大量的參考文獻(xiàn)。同時(shí)，F(xiàn)luorochrome公司特別開發(fā)了高靈敏度的 Fluoro-Gold Antibody 、以及 Fluoro-Ruby（紅色熒光金）等產(chǎn)品，F(xiàn)luorochrome 公司堅(jiān) 持以優(yōu)質(zhì)的產(chǎn)品和熱情的服務(wù)贏得了良好的知名度和口碑。
丁香通-品牌專區(qū)認(rèn)證授權(quán)代理信息：
https://www.biomart.cn/brand/ff80808151482b4d015157247a2467eb/brand.htm
Biosyn公司于1995年創(chuàng)立于美國加州，是一家專業(yè)研發(fā)和生產(chǎn)高質(zhì)量的科研級(jí)別和臨床/GMP血藍(lán)蛋白的生物醫(yī)藥公司。目前biosyn公司生產(chǎn)的血藍(lán)蛋白在大型國際醫(yī)藥公司中有約30%的市場(chǎng)占有率。血藍(lán)蛋白來源于大鎖孔帽貝（透孔螺）的血淋巴，也被叫做匙孔血藍(lán)蛋白，是具有高度免疫原性的蛋白大分子，也是一種多功能蛋白，它不僅具有輸氧功能，而且還與能量的貯存、滲透壓的維持及蛻皮過程的調(diào)節(jié)有關(guān)，還具有酚氧化物酶活性和抗菌功能，被認(rèn)為是節(jié)肢動(dòng)物和軟體動(dòng)物中的一種重要的免疫分子。
Biosyn公司的KLH很好的解決了沉淀問題， 其KLH溶液產(chǎn)品的保質(zhì)期可長達(dá)4年。
傳統(tǒng)凍干粉狀態(tài)KLH會(huì)產(chǎn)生大量沉淀并可能導(dǎo)致在使用該產(chǎn)品過濾沉淀時(shí)損失高達(dá)30%-40%, 好的KLH制劑溶液應(yīng)在結(jié)合前極少沉淀，從而可產(chǎn)生高效的偶聯(lián)和增強(qiáng)抗體反應(yīng)。Biosyn公司于1995年創(chuàng)立于美國加州，是一家專業(yè)同時(shí)研發(fā)和生產(chǎn)高質(zhì)量的科研和臨床級(jí)別血藍(lán)蛋白的生物醫(yī)藥公司。目前biosyn公司生產(chǎn)的血藍(lán)蛋白在大型國際醫(yī)藥公司中有約30%的市場(chǎng)占有率。 Biosyn公司的KLH很好的解決了沉淀問題， 其KLH溶液產(chǎn)品的保質(zhì)期可長達(dá)4年。
About biosyn Corporation Company
biosyn Corporation is a pharmaceutical and biotech company established in 1995 in California. The company is focused on the development, manufacturing and marketing of novel hemocyanin and selenium products.
biosyn hemocyanin and immunocyanin products have since been marketed under the trade name IMMUCOTHEL® and VACMUNE® and are now well recognized quality investigational products and are used extensively as carrier protein for investigation vaccine production and as a tracer molecule in vaccine preparation, as a neoantigen and for immune status evaluation.
biosyn is world leader in the manufacture of high quality, clinical/GMP and research grade hemocyanin product. At present, 3 of the 10 biggest international pharmaceutical companies are using biosyn hemocyanin products for research and development of novel vaccines in advanced stages.
Having successfully registered the biosyn drug product selenase® in Europe, including Russia, as well as in Asian and South American countries, and with the increased interest in selenium usage for clinical investigation in the USA, biosyn filed the Drug Master File with the US FDA in 2008 to enable and support the usage of the biosyn standardized selenium product in investigational studies.
biosyn's future goal is to ensure quality product availability and regulatory support to its current and new customers for investigational and commercial purposes.
Diagnostics Biochem Canada Inc (DBC)公司創(chuàng)立于1973年，是一家40余年專業(yè)研發(fā)生產(chǎn)和銷售診斷和公共健康領(lǐng)域免疫檢測(cè)分析試劑盒的企業(yè)。DBC的創(chuàng)始和研發(fā)人員豐富的研發(fā)經(jīng)驗(yàn)和技術(shù)進(jìn)步使得其意識(shí)到向客戶提供提供簡(jiǎn)單而優(yōu)質(zhì)試劑盒產(chǎn)品的重要性，迄今為止DBC公司已經(jīng)成功研發(fā)了放射免疫（RIA），酶聯(lián)免疫（ELISA），化學(xué)發(fā)光（LIA）分析系列化產(chǎn)品。作為全球高質(zhì)量免疫分析產(chǎn)品的生產(chǎn)商，DBC公司不斷致力于研究開發(fā)新技術(shù)和工藝使得其在診斷試劑和提高人類生活質(zhì)量領(lǐng)域保持領(lǐng)先地位。
DBC公司的診斷試劑產(chǎn)品已通過FDA認(rèn)證。 作為診斷試劑行業(yè)的領(lǐng)導(dǎo)者，在40多年里DBC公司向全球各個(gè)國家和地區(qū)不斷提供著高質(zhì)量和獨(dú)特的診斷試劑盒產(chǎn)品，DBC公司將以此為宗旨并繼續(xù)問為客戶提供更加優(yōu)質(zhì)和有競(jìng)爭(zhēng)力的產(chǎn)品。
At Diagnostics Biochem Canada Inc (DBC) it is has been our mission for over 40 years to develop and market unique immunoassay kits that make a difference in the field of diagnostics and public health. As a manufacturer of high quality immunoassays to a global market, we are constantly looking for new technologies and applications that can lead to an improvement in the diagnosis of disease and ultimately impact the quality of life of people around the world.
DBC was founded in 1973 by a partnership of medical doctors with the initiative to research, develop and market quality radioimmunoassay kits and reagents. As technology in the field progressed the founders of DBC recognized the need to develop simple and non-isotopic kits for our customers. With a strong research initiative, DBC successfully converted from RIA to the ELISA and LIA technologies of today.
We have been exporting our products around the globe for over 40 years. As a leader in the industry, it has always been our goal to offer a wide range of test kits and continually introduce new and unique products to the market place. It is our strong commitment to research and development that has enabled us to offer our customers ongoing and unique products
Diagnostics Biochem Canada Inc.
41 Byron Avenue
Dorchester, Ontario Canada
N0L 1G2
P. (519) 268-8872
F. (519) 268-7167
| |||||||||||
